Turkey’s Coronavirus Scientific Advisory Board to convene today
13 oC
13 oC
Güneşli
13 oC
Güneşli
Coronavirus Scientific Advisory Board will convene on Wednesday under the chairmanship of Health Minister Fahrettin Koca.
The meeting will be held at 17:00 at the campus of Bilkent University in Ankara, the capital of Turkey.
After the meeting, Health Minister Fahrettin Koca is expected to make a statement after the meeting at 19:00 o'clock.
The Coronavirus Scientific Advisory Board of Turkey is a group of medical scientists set up by the Ministry of Health to develop measures in the fight against the coronavirus pandemic in Turkey that are imposed by the government.
The Scientific Advisory Board was set up on 10 January 2020 following the emergence of the coronavirus outbreak, before the World Health Organization confirmed it mid-March as pandemic.
The board consists of 26 members, including 21 university professors and 4 medical experts specialized in Pulmonology, Infectious Diseases, Clinical Microbiology and a legal advisor.
The number of board members increased later to 31 with the joining of expert academics in virology, internal medicine, intensive care medicine. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
A new pilot study suggests that neurofeedback-based digital training may significantly enhance brain function in children diagnosed with dyslexia, offering fresh hope for non-invasive, long-term interventions targeting reading-related neurological challenges.
Influenza cases are rising sharply across Europe, placing growing pressure on hospitals and health systems in many countries, the World Health Organization (WHO) has warned.
Türkiye’s total environmental protection expenditure reached 441 billion Turkish lira in 2024, marking a sharp increase of 108.3 percent compared to the previous year, the Turkish Statistical Institute (TurkStat) said in a statement on Thursday.
A federal judicial panel on Monday ordered that a growing number of lawsuits accusing Novo Nordisk and Eli Lilly of causing vision loss be centralized before a single judge in Pennsylvania, marking a significant new phase in litigation over the widely used weight-loss and diabetes drugs.
